Paediatric chronic hepatitis B virus infection: are children too tolerant to treat?
- PMID: 30362178
- DOI: 10.1111/apa.14626
Paediatric chronic hepatitis B virus infection: are children too tolerant to treat?
Abstract
Aim: Guidelines for managing the hepatitis B (HB) virus infection in children are still evolving. We aimed to assess the eligibility of children with HB virus infections for treatment based on the current guidelines.
Methods: This observational study took place in 2016 and focused on children with isolated chronic HB infections, who attended the paediatric hepatology units at two centres in Egypt. We recruited all treatment-naïve children aged one year to 18 years who had completed at least 12 months of follow-up.
Results: The study comprised 103 children aged between 1.5-18 years. Of these, 51 (50%) had the HB e antigen-positive chronic infection, 28 (27%) had the HB-negative chronic infection, 11 (11%) had the HB e antigen-positive chronic hepatitis and none had the HB e antigen-negative chronic hepatitis. The remaining 13 (12%) children did not fulfil the criteria for chronic HB definitions. Only two of the children were candidates for treatment: both had HB e antigen-positive chronic hepatitis and had undergone liver biopsies.
Conclusion: Only two of the 103 children with chronic HB were eligible for treatment according to the current guidelines and every measure should be taken to prevent the HB virus infection in children.
Keywords: Children; Chronic hepatitis B; HB e antigen-positive chronic hepatitis; Hepatitis B virus; Treatment eligibility.
©2018 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
Comment in
-
Hepatitis B virus and the paediatric liver: waiting for news on the horizon.Acta Paediatr. 2019 Jun;108(6):989-991. doi: 10.1111/apa.14764. Epub 2019 Mar 13. Acta Paediatr. 2019. PMID: 30868651 No abstract available.
Similar articles
-
Combination of Entecavir/Peginterferon Alfa-2a in Children With Hepatitis B e Antigen-Positive Immune Tolerant Chronic Hepatitis B Virus Infection.Hepatology. 2019 Jun;69(6):2326-2337. doi: 10.1002/hep.30312. Epub 2019 Feb 20. Hepatology. 2019. PMID: 30318613 Free PMC article.
-
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.J Hepatol. 2018 Jun;68(6):1123-1128. doi: 10.1016/j.jhep.2018.01.037. Epub 2018 Feb 13. J Hepatol. 2018. PMID: 29452204 Clinical Trial.
-
[Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].Zhonghua Er Ke Za Zhi. 2007 Aug;45(8):592-8. Zhonghua Er Ke Za Zhi. 2007. PMID: 18021533 Clinical Trial. Chinese.
-
Management of chronic hepatitis B infection.Arch Dis Child. 2014 Nov;99(11):1037-42. doi: 10.1136/archdischild-2013-304925. Epub 2014 May 8. Arch Dis Child. 2014. PMID: 24812303 Review.
-
Can we stop nucleoside analogues before HBsAg loss?J Viral Hepat. 2019 Aug;26(8):936-941. doi: 10.1111/jvh.13091. Epub 2019 Mar 27. J Viral Hepat. 2019. PMID: 30803099 Review.
Cited by
-
Prediction for HBsAg seroconversion in children with chronic hepatitis B.BMC Infect Dis. 2021 Dec 4;21(1):1211. doi: 10.1186/s12879-021-06883-1. BMC Infect Dis. 2021. PMID: 34863101 Free PMC article.
-
Successful treatment of infantile hepatitis B with lamivudine: A case report.World J Clin Cases. 2021 May 16;9(14):3442-3448. doi: 10.12998/wjcc.v9.i14.3442. World J Clin Cases. 2021. PMID: 34002156 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources